EUVIMEDEUVIMED entdecken
Crossref

Y‐27632 Suppresses the Growth and Migration of Oral Squamous Cell Carcinoma, but Upregulates Autophagy by Suppressing mTOR Effectors

Jie Wen iD, Yunhan Sun, Li Ma, Tingjian Zu, Na Wang, Tianqi Zhang, Jin Liang, Yulei Zhang, Haoyang Lu, Yihua Wu, Shizhou Zhang

Journal of Oral Pathology & Medicine · 2025

DOI: 10.1111/jop.13603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2025. Verfasst von Jie Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Amides, Pyridines, Cell Movement, Mouth Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Medical and Health Science and Technology Development Project of Shandong Province, National College Students Innovation and Entrepreneurship Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Rho‐associated protein kinase (ROCK) inhibitor Y‐27632 is a potential immunotherapeutic agent for cancer treatment. Y‐27632 blocks the growth and migration of oral squamous cell carcinoma (OSCC) CAL‐27 cells. However, detailed studies on the underlying mechanisms have not yet been reported.

Methods

We investigated the effects of Y‐27632 on the proliferation, migration, and invasion of OSCC cells (CAL‐27, SCC‐4, and SCC‐9) using the Cell Counting Kit‐8 assay, ethynyl‐2′‐deoxyuridine staining, cell scratch, and transwell assay in vitro. Next, ROCK1/2 was knocked down using siRNA to confirm that the effects of Y‐27632 were mediated by the inhibition of ROCK activity. A xenograft mouse model was used to verify the effects of Y‐27632 in vivo. The mechanisms underlying Y‐27632‐induced tumor suppression were detected using western blotting and qRT‐PCR.

Results

Our data demonstrated that Y‐27632 potently inhibited OSCC cells (CAL‐27, SCC‐4, and SCC‐9) by inhibiting ROCK activity. In vivo assays confirmed that Y‐27632 suppressed OSCC growth by reducing cell proliferation. Biochemical assays demonstrated that Y‐27632 inactivated the AKT pathway, and treatment with SC79, an AKT activator, rescued the cell growth and migration inhibition elicited by Y‐27632. Further investigation revealed that Y‐27632 enhanced autophagy by suppressing the AKT/mTOR pathway.

Conclusion

Our study demonstrated that Y‐27632 significantly suppressed the growth and migration of OSCC cells and upregulated autophagy via the AKT/mTOR pathway, thus providing a potential therapeutic drug for patients with OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmidesPyridinesCell MovementMouth NeoplasmsCarcinoma, Squamous CellTOR Serine-Threonine KinasesAutophagyHumansCell Proliferationrho-Associated KinasesAnimalsMiceCell Line, TumorUp-RegulationMice, Nude

Stichwörter der Autor:innen

AKT/mTORRho‐associated protein kinaseY‐27632autophagyoral squamous cell carcinoma

Substanzen

Y 27632AmidesPyridinesrho-Associated KinasesTOR Serine-Threonine KinasesMTOR protein, humanROCK1 protein, human

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • School of Stomatology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Department of Stomatology, Affiliated Hospital of Heze Medical College, Heze, Shandong, China.
  • Department of Periodontology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

ORCID-Profile: Jie Wen

Förderung

  • Medical and Health Science and Technology Development Project of Shandong Province
  • National College Students Innovation and Entrepreneurship Training Program

Zitieren

APA

Wen, J., Sun, Y., Ma, L., Zu, T., Wang, N., Zhang, T., Liang, J., Zhang, Y., Lu, H., Wu, Y., & Zhang, S. (2025). Y‐27632 Suppresses the Growth and Migration of Oral Squamous Cell Carcinoma, but Upregulates Autophagy by Suppressing mTOR Effectors. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13603

Vancouver

Wen J, Sun Y, Ma L, Zu T, Wang N, Zhang T, et al. Y‐27632 Suppresses the Growth and Migration of Oral Squamous Cell Carcinoma, but Upregulates Autophagy by Suppressing mTOR Effectors. Journal of Oral Pathology & Medicine. 2025. doi:10.1111/jop.13603

BibTeX
@article{Wen2025,
  author = {Wen, Jie and Sun, Yunhan and Ma, Li and Zu, Tingjian and Wang, Na and Zhang, Tianqi and Liang, Jin and Zhang, Yulei and Lu, Haoyang and Wu, Yihua and Zhang, Shizhou},
  title = {Y‐27632 Suppresses the Growth and Migration of Oral Squamous Cell Carcinoma, but Upregulates Autophagy by Suppressing mTOR Effectors},
  journal = {Journal of Oral Pathology & Medicine},
  year = {2025},
  doi = {10.1111/jop.13603}
}
Kostenlos starten →